Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:1026-1028
Published online before print October 30, 2003, doi: 10.1161/01.RES.0000104084.88317.91
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
93/11/1026    most recent
01.RES.0000104084.88317.91v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Muslin, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Muslin, A. J.
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
(Circulation Research. 2003;93:1026.)
© 2003 American Heart Association, Inc.


Reports

Role of 14-3-3-Mediated p38 Mitogen-Activated Protein Kinase Inhibition in Cardiac Myocyte Survival

Shaosong Zhang, Jie Ren, Cindy E. Zhang, Ilya Treskov, Yibin Wang, Anthony J. Muslin

From the Center for Cardiovascular Research, Departments of Medicine (S.Z., J.R., C.E.Z., I.T., A.J.M.) and Cell Biology and Physiology (S.Z., J.R., C.E.Z., A.J.M.), Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology and Medicine (Y.W.), David Geffen School of Medicine, UCLA, Los Angeles, Calif.

Correspondence to Anthony J. Muslin, Center for Cardiovascular Research, Box 8086, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110. E-mail amuslin{at}im.wustl.edu

Abstract

14-3-3 family members are dimeric phosphoserine-binding proteins that regulate signal transduction, apoptotic, and checkpoint control pathways. Targeted expression of dominant-negative 14-3-3{eta} (DN-14-3-3) to murine postnatal cardiac tissue potentiates Ask1, c-jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) activation. DN-14-3-3 mice are unable to compensate for pressure overload, which results in increased mortality, dilated cardiomyopathy, and cardiac myocyte apoptosis. To evaluate the relative role of p38 MAPK activity in the DN-14-3-3 phenotype, we inhibited cardiac p38 MAPK activity by pharmacological and genetic methods. Intraperitoneal injection of SB202190, an inhibitor of p38{alpha} and p38ß MAPK activity, markedly increased the ability of DN-14-3-3 mice to compensate for pressure overload, with decreased mortality. DN-14-3-3 mice were bred with transgenic mice in which dominant-negative p38{alpha} (DN-p38{alpha}) or dominant-negative p38ß (DN-p38ß) MAPK expression was targeted to the heart. Compound transgenic DN-14-3-3/DN-p38ß mice, and to a lesser extent compound transgenic DN-14-3-3/DN-p38{alpha} mice, exhibited reduced mortality and cardiac myocyte apoptosis in response to pressure overload, demonstrating that DN-14-3-3 promotes cardiac apoptosis due to stimulation of p38 MAPK activity.


Key Words: signal transduction • apoptosis • cardiac • 14-3-3 protein • p38 mitogen-activated protein kinase




This article has been cited by other articles:


Home page
DevelopmentHome page
N. Jin, S.-N. Cho, M. G. Raso, I. Wistuba, Y. Smith, Y. Yang, J. M. Kurie, R. Yen, C. M. Evans, T. Ludwig, et al.
Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis
Development, October 1, 2009; 136(19): 3347 - 3356.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini
Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta}
Circ. Res., March 16, 2007; 100(5): e59 - e71.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K.-i. Watanabe, M. Ma, K.-i. Hirabayashi, N. Gurusamy, P. T. Veeraveedu, P. Prakash, S. Zhang, A. J. Muslin, M. Kodama, and Y. Aizawa
Swimming stress in DN 14-3-3 mice triggers maladaptive cardiac remodeling: role of p38 MAPK
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1269 - H1277.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Vahebi, A. Ota, M. Li, C. M. Warren, P. P. de Tombe, Y. Wang, and R. J. Solaro
p38-MAPK Induced Dephosphorylation of {alpha}-Tropomyosin Is Associated With Depression of Myocardial Sarcomeric Tension and ATPase Activity
Circ. Res., February 16, 2007; 100(3): 408 - 415.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. C. Lau, X. Jin, J. Ren, J. Avery, B. J. DeBosch, I. Treskov, T. S. Lupu, A. Kovacs, C. Weinheimer, and A. J. Muslin
The 14-3-3{tau} Phosphoserine-Binding Protein Is Required for Cardiomyocyte Survival
Mol. Cell. Biol., February 15, 2007; 27(4): 1455 - 1466.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Tao, X. Jiao, E. Gao, W. B. Lau, Y. Yuan, B. Lopez, T. Christopher, S. P. RamachandraRao, W. Williams, G. Southan, et al.
Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis
Circulation, September 26, 2006; 114(13): 1395 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Anselmi, M. Lotrionte, G. G.L. Biondi-Zoccai, L. Galiuto, and A. Abbate
Left ventricular hypertrophy, apoptosis, and progression to heart failure in severe aortic stenosis
Eur. Heart J., December 2, 2005; 26(24): 2747 - 2747.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Katada, H. Saito, and A. Ohashi
Significance of Cyclooxygenase-2 Induced via p38 Mitogen-Activated Protein Kinase in Mechanical Stimulus-Induced Peritoneal Adhesion in Mice
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 286 - 292.
[Abstract] [Full Text] [PDF]